Join
Live feed
·
PRReleasevia Quantisnow
Immunome Inc. logo

Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting

ByQuantisnow·Wall Street's wire, on your screen.
IMNM· Immunome Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMNM (Immunome Inc.) and more on Quantisnow.